Chairman Kim Jong-ho of Kibo Visits Companies Facing Challenges with Killer Regulations
Listening to Challenges of Killer Regulations in the Bio Industry
The Korea Technology Finance Corporation (hereinafter referred to as Kibo) announced that Chairman Kim Jong-ho visited BioComplet (CEO Heo Jae-eok), located in Guro-gu, Seoul, on the 30th to listen to the key regulatory challenges in the bio industry and discuss regulatory improvement measures aligned with global standards.
BioComplet is a specialized company in bio clinical trial research and analysis, holding numerous patents related to protein commercialization. It is an excellent technology-based small and medium enterprise growing annually through research and development (R&D) commercialization. Kibo evaluated the technological value of patents related to protein commercialization and supported their commercialization. Additionally, Kibo has continuously provided various products suitable for all stages of corporate growth, including R&D development funds and working capital.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Chairman Kim toured the R&D facilities with CEO Heo Jae-eok and stated, "Kibo will provide focused support through customized products so that advanced technology companies in ultra-gap fields can scale up and leap to become global top-tier companies." He added, "Furthermore, we will actively work to resolve regulations in advanced strategic industries to comply with the global standard principle led by the government."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
